Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Impact of Treatment Adherence on Efficacy of Dolutegravir + Lamivudine and Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Week 144 Analysis of the GEMINI-1 and GEMINI-2 Clinical Studies.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: October 18, 2023
Number of Sexual Partners and Patient-Reported Outcomes Among Men Age 50+ with HIV.
Journal: AIDS research and human retroviruses
Published: June 28, 2023
Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 23, 2023
Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks.
Journal: Open forum infectious diseases
Published: November 17, 2022
Evaluating Diversity in Randomized Clinical Trials of Dolutegravir-Based Antiretroviral Therapy Regimens: Pooled 48-Week Analyses by Race, Sex, and Regional Subgroups.
Journal: Open forum infectious diseases
Published: March 31, 2022
Impact of treatment adherence on efficacy of dolutegravir plus lamivudine and dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled analysis of the GEMINI-1 and GEMINI-2 clinical studies.
Journal: HIV research & clinical practice
Published: December 16, 2021
Factors Associated with Resilience Among Older People Living with HIV.
Journal: AIDS and behavior
Published: October 10, 2021
Association of Pain and Pain Medication Use with Multiple Characteristics of Older People Living with HIV.
Journal: AIDS research and human retroviruses
Published: June 10, 2020
Short Communication: Dolutegravir-Based Regimens Are Active in Integrase Strand Transfer Inhibitor-Naive Patients with Nucleoside Reverse Transcriptase Inhibitor Resistance.
Journal: AIDS research and human retroviruses
Published: February 16, 2018
Last Updated: 09/26/2026